Testing effectiveness (Phase 2)WithdrawnNCT01740570What this trial is testingPhase I/II Cabazitaxel for Recurrent Malignant GliomaWho this might be right forBrain Cancer M.D. Anderson Cancer Center
Not applicableEnded earlyNCT00471653What this trial is testingPharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation TherapyWho this might be right forBrain and Central Nervous System TumorsThrombocytopenia Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 10